Anesthetic Isoflurane Posttreatment Attenuates Experimental Lung Injury by Inhibiting Inflammation and Apoptosis

We investigated the effect of 1.4% isoflurane (ISO) on the development of inflammation and apoptosis caused by zymosan (ZY) in mice. We found that ZY-challenged mice exhibited significant body weight loss, markedly high mortality, and significant lung injury characterized by the deterioration of his...

Full description

Saved in:
Bibliographic Details
Main Authors: Jun-tang Li (Author), Hui Wang (Author), Wei Li (Author), Li-feng Wang (Author), Li-chao Hou (Author), Jing-lan Mu (Author), Xin Liu (Author), Hui-juan Chen (Author), Ke-lang Xie (Author), Nan-lin Li (Author), Chun-fang Gao (Author)
Format: Book
Published: Hindawi Limited, 2013-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_c38d42b3b4774dbfa5211e7de10373f5
042 |a dc 
100 1 0 |a Jun-tang Li  |e author 
700 1 0 |a Hui Wang  |e author 
700 1 0 |a Wei Li  |e author 
700 1 0 |a Li-feng Wang  |e author 
700 1 0 |a Li-chao Hou  |e author 
700 1 0 |a Jing-lan Mu  |e author 
700 1 0 |a Xin Liu  |e author 
700 1 0 |a Hui-juan Chen  |e author 
700 1 0 |a Ke-lang Xie  |e author 
700 1 0 |a Nan-lin Li  |e author 
700 1 0 |a Chun-fang Gao  |e author 
245 0 0 |a Anesthetic Isoflurane Posttreatment Attenuates Experimental Lung Injury by Inhibiting Inflammation and Apoptosis 
260 |b Hindawi Limited,   |c 2013-01-01T00:00:00Z. 
500 |a 0962-9351 
500 |a 1466-1861 
500 |a 10.1155/2013/108928 
520 |a We investigated the effect of 1.4% isoflurane (ISO) on the development of inflammation and apoptosis caused by zymosan (ZY) in mice. We found that ZY-challenged mice exhibited significant body weight loss, markedly high mortality, and significant lung injury characterized by the deterioration of histopathology, histologic scores, and wet-to-dry ratio after ISO treatment. ISO dramatically attenuated ZY-induced lung neutrophil recruitment and inflammation, as evidenced by the reduced levels of total cells, neutrophils, and proinflammatory cytokines (i.e., tumor necrosis factor-α, interleukin- (IL-) 1β, IL-6, and macrophage inflammatory protein-2) in bronchoalveolar lavage fluid and of their mRNA expression in lung tissues. ISO also inhibited ZY-induced expression and activation of nuclear factor-kappaB p65 and inducible nitric oxide synthase in pulmonary tissue. ZY administration also resulted in the upregulation of heme oxygenase-1 expression and activity in the lung, which was further enhanced by ISO treatment. Moreover, ISO markedly prevented ZY-induced pulmonary cell apoptosis in mice, as reflected by the decrease in expression of procaspase-8, procaspase-3, cleaved caspase-8, and cleaved caspase-3, as well as in caspase-3 activity and Bcl-2-associated X/B-cell lymphoma 2 ratio. These results indicate that ISO is a potential therapeutic drug for treating ZY-induced lung injury, and further investigations are warranted. 
546 |a EN 
690 |a Pathology 
690 |a RB1-214 
655 7 |a article  |2 local 
786 0 |n Mediators of Inflammation, Vol 2013 (2013) 
787 0 |n http://dx.doi.org/10.1155/2013/108928 
787 0 |n https://doaj.org/toc/0962-9351 
787 0 |n https://doaj.org/toc/1466-1861 
856 4 1 |u https://doaj.org/article/c38d42b3b4774dbfa5211e7de10373f5  |z Connect to this object online.